Fig. 3From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individualsFirst scenario: primovaccination in adults. Antibody curve ( ) generated by the model for 10,000 days of simulation and experimental data ( ) obtained from primo-vaccinated individuals in the same period. The red dashed line ( ) presents the protective levelBack to article page